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Abstract
Background: Hypertrophic olivary degeneration (HOD) is a rare phenomenon, probably related to transsynaptic degeneration of the inferior olivary nucleus. It
usually occurs as a response to primary injury of dento-rubro-olivary pathways.
Case report: A young man developed Holmes’ tremor 7 months after a cavernous malformation bleed in the midbrain. Typical findings of HOD were observed
in the magnetic resonance images: bilateral and asymmetric hypertrophy of the olivary nucleus with slight hypersignal in T2-weighted images. Because of the
striking disability related to drug-resistant tremor, the patient underwent stereotactic thalamotomy (nucleus ventralis intermedius of the thalamus/zona incerta) with
pronounced functional improvement over time.
Discussion: Disruption of circuits in the Guillain–Mollaret triangle classically results in palatal myoclonus, however midbrain (Holmes’) tremor can also occur, as
we now describe.
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Introduction
Hypertrophic olivary degeneration (HOD) is a rare form of
neuronal degeneration that occurs secondary to injuries that disrupt
normal function of the afferent fibers to the inferior olivary nucleus
(ION) as part of the dentate-rubro-olivary pathways (triangle of
Guillain–Mollaret).1 The first description of HOD was published by
Oppenheim in 1887, and the development of HOD was further
described by Guillain and Mollaret in 1931.2,3
Insults to this pathway are commonly related to vascular disease,
either infarction or hemorrhage. However, HOD may occur after
head trauma, tumor, demyelinating or degenerative diseases, and after
surgical manipulation.1,4 HOD is best observed using magnetic
resonance imaging (MRI), where it appears as an enlargement of the
ION, with increased signal on T2-weighted images.5
Symptomatic palatal tremor is a well-defined movement disorder
that appears after lesions involving the Guillain–Mollaret triangle and
is classically associated with HOD.2–4 Although almost all cases of
palatal tremor present with HOD, not all cases of HOD are
accompanied by palatal tremor.6 Dentato-rubral tremor, or Holmes’
tremor (HT), is a different clinical entity that can be (but is
infrequently) accompanied by HOD. HT is a symptomatic tremor
that presents with high-amplitude and low-frequency rhythmic
complex movements. It usually arises as a delayed manifestation of
lesions in the upper brainstem, often related to stroke or head trauma.
The Consensus Statement of the Movement Disorder Society on
tremor, published in 1998, stated that both the dopaminergic
nigrostriatal and the cerebellum–thalamic systems are involved in
the occurrence of this type of tremor. Recently, HT associated with a
brainstem lesion has been reported as a fairly rare type of tremor.7
In the present report, a patient who was diagnosed with HT after a
hemorrhage in the midbrain related to a cavernous malformation
showed signs of HOD on MRI scans.
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Case report
A 27-year-old male with a past history of chronic headache
presented with a severe thunderclap headache followed by acute left-
sided weakness, diplopia, right-eyelid ptosis, and moderate dysarthria.
Seven months later he developed severe tremor on his left side.
Initially, the tremor arose in his arm and gradually spread to his leg,
with proximal involvement worse than distal involvement. Early
follow-up MRI showed a rim of low signal due to hemosiderin on a
gradient echo sequence without any mass effect or contrast enhance-
ment (gadolinium), confirming a cavernous malformation in the right
midbrain and evidence of prior surrounding hemorrhage. Four years
after onset of the original headache, the MRI revealed asymmetric
enlargement of the olivary nuclei, slightly more prominent on the
right, with pronounced hyperintensity in T2 images and reduced
intensity in fluid-attenuation inversion recovery (FLAIR) images
consistent with HOD. No contrast enhancement (gadolinium) was
observed (Figure 1).
The patient was referred to our neurosurgical unit and examination
revealed a severe rest tremor that was incessant, worsened with
posture, and amplified during intentional movements, with a low
frequency of 4 Hz and featuring a typical clinical picture of a severe
HT. Furthermore, the tremor caused severe functional impairment
and prevented the patient from standing up.
Despite medical treatment with various drugs (trihexyphenidyl
6 mg/day, primidone 500 mg/day, clonazepam 6 mg/day, and
propranolol 120 mg/day), the patient did not experience satisfactory
tremor control. At this point, the stereotactic procedure was presented
as a therapeutic option. An ablative procedure was performed in the
zona incerta in the right side, including the bottom of the nucleus
ventralis intermedius of the thalamus (VIM). The tremor was markedly
reduced after the procedure. The previous clinical scenario of left
hemiparesis, right third nerve palsy, and dysarthria were unchanged.
Over 95% of the improvement in the tremor was observed directly
after the procedure. This improvement was maintained up to the latest
follow-up appointment, which was around 5 years after the operation.
The patient also reported a significant improvement in quality of life
and social interaction. The abolition of tremor made rehabilitation
possible, and the patient’s posture and muscle strength improved over
time. Neither palatal nor ocular tremor was observed during the last
follow-up.
Discussion
HOD is a unique transsynaptic neuronal degeneration caused by
lesions in the circuit of the Guillain–Mollaret triangle. It is defined by
three anatomical structures: the dentate nucleus in the cerebellum, the
contralateral red nucleus at the level of the midbrain, and the
contralateral ION in the medulla oblongata. The dentate nucleus
afferents travel via the superior cerebellar peduncle and cross the
midline towards the contralateral red nucleus. From the red nucleus,
fibers descend in the central tegmental tract to enter the ION. The
ION sends its afferents via climbing fibers in the inferior cerebellar
peduncle to Purkinje cells of the contralateral cerebellar cortex. The
Purkinje cells send their afferents to the ipsilateral dentate nucleus, thus
completing the triangle. This triangular circuit exhibits bi-directional
pathways between the dentate nucleus and the contralateral ION,
creating a coupled feedback control system. The inferior olive tends to
demonstrate a slow, rhythmic, spontaneous activity. ION deafferenta-
tion may cause hypersensitivity denervation followed by HOD.3,8,9
While transsynaptic neuronal degeneration associated with atrophy
of the targeted structure is a common response to a confined lesion
(e.g., atrophy of the mammillary bodies in lesions involving the fornix),
such degeneration resulting in hypertrophy of the targeted region is
unique to the ION.1,10 Post-mortem studies reveal large neuronal cell
bodies approximately 3 weeks after the causative event, with a peak in
neuronal and glial growth observed at 8–9 months. Pseudohyper-
trophy (neuronal dissolution and gemistocytic astrocytic reaction)
Figure 1. Four-year Follow-up Magnetic Resonance Imaging. (A,B) serial T2-weighted and (C,D) fluid-attenuation inversion recovery (FLAIR) images showing
the olivary nucleus. There is a hyperintense signal in the inferior olivary nucleus bilaterally, signal in T2 more pronounced than FLAIR, and enlargement of olives,
slightly more prominent on the right, consistent with HOD. (E) T1-gadolinium image with no enhancement. (F) A rim of signal loss due to hemosiderin on gradient echo
sequence, confirming a cavernous malformation on the right midbrain and prior surrounding hemorrhage.
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follows that stage and is usually maintained for several months. Finally,
the olivary nucleus atrophies more than a year after injury.3,4,9,10
HOD’s hallmarks include hypertrophy of the olive with increased
T2 signal intensity on MRI, which are correlated with the pathological
findings. In the first 6 months following the onset of HOD, there is an
increased signal on T2 with normal looking inferior olives. The second
stage lasts for about 3 to 4 years and demonstrates an increased signal
with evidence of olivary pseudohypertrophy. During the third stage,
the atrophy follows the hypertrophy as it resolves, but persistent high-
signal T2 can be observed.2,5
The differential diagnosis of signal hyperintensity on T2-weighted
images within the pontomedullary region includes tumors (malignan-
cies such as primary brainstem astrocytoma or metastasis), demyeli-
nating lesions, infarction, and inflammatory processes (tuberculosis,
sarcoidosis, or encephalitis). The lack of contrast enhancement,
however, makes hypothetical malignancies and infectious disease less
likely to be the cause, while the enlargement of the olivary nucleus
itself weans chronic stages of infarction or multiple sclerosis. Therefore,
in the setting of a T2-hyperintense non-contrast enhancing lesion,
which is accompanied by enlargement of the olivary nucleus, HOD
remains the sole diagnosis that explains all of the imaging findings.
Identifying an inciting lesion appropriately located to interrupt the
dentate-rubro-olivary tracts with the correct timing of the signal
change and swelling is the key to diagnosis.1,4,10
The clinical manifestation offered by alterations in the Guillain–
Mollaret triangle can be quite diverse, and still no unifying theory able
to link the pathological changes and the resulting clinical picture has
been postulated.3 Classically, palatal tremor is the most reported
neurological sign that accompanies HOD. However, the incidence of
HOD after brainstem injury is unknown and the occurrence of palatal
tremor with HOD is also variable.4
Unusually, other movement disorders can also occur in association
with HOD, presenting as HT or ocular myoclonus. Recently, HT
associated with a brainstem lesion has been reported as an extremely
rare tremor, along with drug-induced tremor, orthostatic tremor, and
psychogenic tremor. Furthermore, descriptions of HT associated with
HOD are even scarcer.7 Although lower brainstem hemorrhage is
among several common causes of HOD, it has not been appreciated as a
cause of midbrain (‘‘rubral’’) tremor. It is most likely that disynaptic
dentate-rubro-olivary tract degeneration (associated with tremor) and
the monosynaptic dentate-olivary tract (associated with HOD) are both
components of the rubro-olive-cerebello-rubral loop implicated in
midbrain tremors. Their functional convergence makes the combination
of tremor and HOD after brainstem damage plausible and even likely.6
Pharmacological treatment of HT is usually disappointing, so
stereotactic ablative procedures (thalamotomy) or deep brain stimula-
tion are often required in refractory cases and provide encouraging
results.11 Many treatment methods have been tried; however, no gold
standard treatments currently exist for HT.7
HOD is a unique pathological entity that occurs variably after injury
to the brainstem. Specifically, injury to the dentate-rubro-olivary
pathway can result in HOD, which may be associated with palatal
tremor and, less often, HT or ocular myoclonus. However, the
possibility of developing HOD and its clinical sequelae is a relevant
concern for clinicians and patients. Whenever changes are observed in
the MRI images that suggest HOD, a simple but careful examination
of the pharynx, larynx, and ocular movements should be performed.
HOD after injury to any component of the triangle of Guillain–
Mollaret should not be confused with neoplastic, vascular, or other
primary pathological conditions of the medulla. When HOD is
considered in the differential diagnosis, patients can be counseled
appropriately, and treatment can be initiated.
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